Huge trial casts doubt on bisphosphonates for breast cancer
Pediatric News ,
Five years of treatment with bisphosphonates after chemotherapy for high-risk early breast cancer is too much, say researchers…
Five years of treatment with bisphosphonates after chemotherapy for high-risk early breast cancer is too much, say researchers…
Five years of treatment with bisphosphonates after chemotherapy for high-risk early breast cancer is too much, say researchers…
Oncology/Hematology > Breast Cancer No survival benefit beyond 2 years of use in high-risk early disease Adjuvant…